Here, we applied PrediXcan to data on patients with RA receiving anti-TNF treatment from the MAximising Therapeutic Utility for Rheumatoid Arthritis (MATURA) consortium,8 focusing on testing the association between the change in erythrocyte sedimentation rate (ESR) and predicted gene expression. This evidence concerns the gene TNF and rheumatoid arthritis.